Waldenström's macroglobulinemia history and symptoms

Jump to navigation Jump to search

Waldenström's macroglobulinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Waldenström's macroglobulinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Bone Marrow Aspiration and Biopsy

Electrophoresis and Immunofixation

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Waldenström's macroglobulinemia history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Waldenström's macroglobulinemia history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Waldenström's macroglobulinemia history and symptoms

CDC on Waldenström's macroglobulinemia history and symptoms

Waldenström's macroglobulinemia history and symptoms in the news

Blogs on Waldenström's macroglobulinemia history and symptoms

Directions to Hospitals Treating Waldenström's macroglobulinemia

Risk calculators and risk factors for Waldenström's macroglobulinemia history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2] Roukoz A. Karam, M.D.[3]

Overview

Many patients with Waldenström macroglobulinemia are asymptomatic. The disease is subtle and symptoms are nonspecific, but the most common symptoms of Waldenström macroglobulinemia include weakness, anorexia, blurry vision, peripheral neuropathy, and weight loss. Less common symptoms of the disease include bleeding and Raynaud phenomenon.

History and Symptoms

History

  • The onset of Waldenström macroglobulinemia is insidious and non-specific.
  • Approximately 25% of patients with WM are asymptomatic upon presentation; their diagnosis is often made incidentally from routine blood tests done for some other reason. WM found this way is sometimes called asymptomatic or Smoldering WM (SWM).[1]
  • Symptoms develop depending on the tissues involved in the malignant cell infiltration or IgM deposition.[2]

Manifestations of WM

Manifestations of WM
Cause Manifestations
Tumor infiltration Cytopenia, fever, night sweats, weight loss, lymphadenopathy, hepatomegaly, spleenomegaly, pulmonary infiltrates, nodules or masses, pleural effusion, abdominal pain, swelling and blood in stools secondary to stomach and bowel infiltration, renal and perirenal masses, maculopapular lesions, plaques or nodules secondary to dermis infiltration, lesions involving retro-orbital lymphoid tissue and lacrimal glands, infiltration of the conjunctiva and malignant vitreitis, Bing-Neel syndrome consists of confusion, memory loss, disorientation, motor dysfunction, and eventually coma.
Circulating monoclonal IgM Hyperviscosity, cryoglobulinemia (consists of Raynaud's phenomenon, skin ulcers & necrosis and cold urticaria), cold agglutinin, neuropathy, amyloidosis, frequent bruising, prolonged bleeding and clotting times.
IgM Deposition Into Tissues Sub-endothelial deposits in glomerular loops leading to non-selective proteinuria, dehydration, and uremia, Firm, flesh-colored skin papules and nodules have been reported and are called macroglobulinemia cutis, Diarrhea, malabsorption, or gastrointestinal bleeding.
Amyloidogenic Properties of IgM Organs more commonly affected by amyloidosis were the heart (44%), the peripheral nerves (38%), the kidneys (32%), the soft tissues (18%), the liver (14%), and lungs (10%), nephrotic syndrome and gastrointestinal involvement.
Autoantibody Activity of IgM Distal, symmetric, chronic demyelinating peripheral neuropathy, Type II cryoglobulinemia characterized by vasculitis affecting small vessels of skin, kidneys, liver, and peripheral nerves, Extravascular chronic hemolytic anemia called cold agglutinin disease exacerbated by cold exposure, glomerulonephritis, paraneoplastic pemphigus, and retinitis.

Common Symptoms

Common symptoms of Waldenström macroglobulinemia include:[1][3]

  • Constitutional B symptoms as seen in other types of NHL:
    • Weakness (due to normocytic anemia associated with IgM binding to RBCs).
    • Anorexia.
    • Unexplained weight loss.
    • Unexplained fever.
    • Heavy sweating, especially at night causing drenching of one's cloths and bedsheet.
    • Severe/extensive skin itchiness.
  • Fatigue.
  • Sensorimotor peripheral neuropathy (mostly associated with numbness and tingling, i.e. painful pins and needle sensation, of the fingers or toes).
  • Blurry vision or blind spots.
  • Abdominal pain.

Less Common Symptoms

Less common symptoms of Waldenström macroglobulinemia include:[1][3]

  • Enlarged lymph nodes (appearing as 1-2 inches sized lumps under the skin in neck, groin or the armpits).
  • Swollen belly/abdomen (due to hepatosplenomegaly).
  • Headache.
  • Raised pink/flesh-colored lesions on skin.
  • Altered mental status due to decreased blood flow and infiltration of CNS leading to:
  • Symptoms resembling stroke like slurred speech or weakness on one side of body (such patients are advised to consult from their doctor right away).
  • Abnormal mucous membrane bleeding (epistaxis, bleeding gums).
  • Vision problems (blurred vision, double vision or blind spots).
  • Kidney problems (leading to weakness, trouble breathing and fluid buildup in body tissues associated with accumulation of excess salt, fluid and waste products in blood secondary to amyloidosis).
  • Heart problems (Secondary to amyloidosis, build up of M protein in heart affects its pumping ability, and also the heart has to work harder to pump the thick blood ultimately leading to CHF with following symptoms).
    • Palpitations.
    • Feeling of tiredness and weakness.
    • Cough.
    • Shortness of breath.
    • Rapid weight gain.
    • Swelling of feet and legs.
  • Infections (high levels of abnormal antibody in WM slows down the production of normal antibodies).
  • Digestive problems due to deposition of IgM protein in the lamina propria of the intestinal wall include:
    • Diarrhea.
    • Poor absorption of vitamins.
    • GIT bleeding/steatorrhea (blood in stools/dark stools).
  • Sensitivity to cold (Raynaud's phenomenon due to cryoglobulinemia in 5% WM patients), which is associated with reduced blood flow leading to pain, itching, bluish discoloration or sores in following body parts:
    • Tip of nose.
    • Ears.
    • Fingers.
    • Toes.
  • Cryoglobulinemia also leads to:
    • Numbness and tingling in hands and feet.
    • Joint aches.
    • Small bruises.
    • Skin ulcers.

Symptoms Secondary to Hyperviscosity Syndrome

The lymphoma cells make varying amounts of a monoclonal protein called immunoglobulin M (IgM, or macroglobulin). Higher amounts of this protein than normal in blood tends to make it thick leading to hyperviscosity syndrome which occurs in approximately 15-20% patients of WM. When blood becomes thick, it is harder for blood to flow through small blood vessels, and when this occurs, the condition is termed as Waldenstrom macroglobulinemia. This excess amount of IgM antibodies can be ultimately associated with circulatory problems leading to less blood flow to the brain, the eyes or other organs.Clinical manifestations of hyperviscosity syndrome occur only if serum viscosity is >4 centipoises and include:[1]

References

  1. 1.0 1.1 1.2 1.3 García-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A; et al. (2001). "Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases". Br J Haematol. 115 (3): 575–82. PMID 11736938.
  2. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M (2000). "Waldenström's macroglobulinemia: clinical features, complications, and management". J Clin Oncol. 18 (1): 214–26. doi:10.1200/JCO.2000.18.1.214. PMID 10623712.
  3. 3.0 3.1 Merlini G, Baldini L, Broglia C, Comelli M, Goldaniga M, Palladini G; et al. (2003). "Prognostic factors in symptomatic Waldenstrom's macroglobulinemia". Semin Oncol. 30 (2): 211–5. doi:10.1053/sonc.2003.50064. PMID 12720138.

Template:WH Template:WS